Key Drivers
- Strong FCF
- Low leverage
- High intangibles
AIAI Summary
CTS has shifted from a cyclical single-product supplier to a cash-rich, acquisition-augmented industrial/medical/aerospace platform where valuation should be anchored to durable free-cash-flow and multi-year design-in visibility rather than historical transportation cyclicality. Key actionable risk: monitor post-deal ROIC and goodwill/intangible impairment risk (and use tighter position sizing or a stop below $45.8 given elevated volatility) — sustained margin/FCF deterioration would rapidly invalidate the thesis.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong FCF
- •Low leverage
- •High intangibles
CTS generates strong free cash flow and delivers efficient returns with modest leverage, but its large intangible asset base and recent negative quarterly cash flow raise impairment and short-term cash concerns. #cash-generative #intangible-risk
Price Behavior
Key Price Behavior Insights:
- •Short-term downtrend
- •Below 21-day SMA
- •Near lower range
CTS has fallen sharply over the last month (from $53.75 to $46.17, ~14%), trading below its last-month 21-day SMA (~$49.60) which signals negative momentum with support near $45.80 and resistance around $49.60–low-$50s.
~14% drop over last month with elevated daily volatility (low-$40s to low-$50s)
Sentiment & News
Key News Insights:
- •Accretive acquisitions
- •Design-in stickiness
- •Pricing competition
Analysts reiterate Buy on CTS, citing accretive M&A and sticky design-ins that provide multi-year revenue visibility despite pricing pressure and peer-relative valuation scrutiny. #AccretiveM&A
The combination of inorganic growth and contract-like revenue visibility supports near-term revenue and margin upside to justify the Buy stance, though pricing pressure could limit valuation expansion
Similar Companies in Technology
Other companies in the same sector with AI ratings